An observational study in Chronic Pain and Obstructive Sleep Apnea, sponsored by Vrije Universiteit Brussel. Recruiting at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Vrije Universiteit Brussel · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Chronic Pain by Vrije Universiteit Brussel — 4 open to participants now, 4 under way, none of them phase 3. Chronic Pain · Vrije Universiteit Brussel.
Among the 16 studies in Chronic Pain by Vrije Universiteit Brussel, this one is one of 3 that started in 2025, is one of 6 observational ones, and was the 14th registered.
3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.
Browse Chronic Pain studies →4 of the 16 studies in Chronic Pain by Vrije Universiteit Brussel are open now, in 2 countries. Recruiting first, the newest first:
Vrije Universiteit Brussel · Sites in Belgium
Ages 18–70 · Healthy volunteers
Vrije Universiteit Brussel · Sites in Belgium
Ages 18–60 · Healthy volunteers
Vrije Universiteit Brussel · Sites in Belgium, Netherlands
Ages 18–65
By country, each count listing its studies:
Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 3 started in 2025.
This study's planned enrollment of 200 is above the median of 120 across 755 observational studies indexed under Chronic Pain.
Median enrollment 57 across the 10 interventional studies, 82 across the 6 observational. Of the 10 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Vrije Universiteit Brussel is the lead sponsor of 160 studies on the registry; 43 are open to participants now.
1 of the studies in Chronic Pain by Vrije Universiteit Brussel that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06834724Vrije Universiteit BrusselClinical Outcomes of Continuous Positive Airway Pressure Treatment in People With Obstructive Sleep Apnea and Chronic Pain | 2027-04 |
Add it to your calendar (.ics) → With an account.
Among the 16 studies in Chronic Pain by Vrije Universiteit Brussel, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The bidirectional link between sleep and pain is widely accepted. However, studies investigating obstructive sleep apnoea (OSA) and chronic pain remain scarce, especially in the context of continuous positive airway pressure (CPAP) therapy. In this study, people recently diagnosed with OSA who are starting CPAP therapy complete questionnaires at baseline and at 3- and 6-month follow-up, and device-recorded CPAP adherence data are collected at routine clinical follow-up. Data from people with and without chronic pain are collected to answer several clinically relevant questions. The primary questions investigate: 1) the association between CPAP use and pain intensity at 3-month follow-up; 2) the association between the baseline apnoea-hypopnoea index (AHI) and pain intensity at 3-month follow-up; and 3) differences in device-recorded CPAP use between people with and without chronic pain and with and without comorbid insomnia (COMISA). Secondary questions investigate CPAP adherence, the prevalence of chronic pain, the relevance of comorbid insomnia, and clinical outcomes of CPAP therapy in people with chronic pain.
OVERVIEW In this study, participants with obstructive sleep apnoea (OSA) who start continuous positive airway pressure (CPAP) treatment complete questionnaires at baseline and at two follow-up time points (3 and 6 months after the start of CPAP treatment). Together with device-recorded CPAP adherence data and data from the polysomnography every participant undergoes before starting CPAP, this allows us to investigate relevant outcomes of CPAP therapy in people with chronic pain (CP).
- Recruitment continues until 200 participants are enrolled, with the aim of including approximately 80 participants with CP.
GROUPS - Participants are classified at baseline as OSA only; OSA with CP; OSA with comorbid insomnia (COMISA, Insomnia Severity Index >= 15); or COMISA with CP.
CPAP ADHERENCE
PRIMARY RESEARCH QUESTIONS
SECONDARY RESEARCH QUESTIONS - LONGITUDINAL
EXPLORATORY RESEARCH QUESTIONS
PUBLICATIONS
- Results will be reported in several publications grouped by theme (baseline characteristics, CPAP adherence, and pain and clinical outcomes of CPAP therapy). Each publication will refer to this registration and state which of the registered research questions it addresses.
REGISTRATION AMENDMENT (NOVEMBER 2026)
The target group for the study consists of adult, Dutch, French or Englisch speaking patients who have been referred to the sleep clinic. These patients have been diagnosed with OSA and will start to receive CPAP treatment. They are included independent of their chronic pain status but some analyses will be done in sub-groups.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Adults with clinically relevant obstructive sleep apnoea (AHI ≥ 15) newly starting CPAP therapy as part of standard care, with or without chronic pain. For analyses, participants are classified at baseline into four subgroups: OSA only; OSA with chronic pain; OSA with comorbid insomnia (COMISA, Insomnia Severity Index ≥ 15); and COMISA with chronic pain.
Other: Standard OSA care
All people will undergo standard care.
Average Pain during last 1 week
Participants are asked for the average pain they had during the last 1 week. They answer on a scale for 0-10 with 0 being no pain and 10 being the worst pain ever. This is a single question taken from the Brief Pain Inventory
Time frame: 3-months after initiation of CPAP therapy
Device-recorded CPAP use at 3 months
Mean nightly CPAP use (hours/night, averaged over all nights in the monitoring period including nights without use), from the CPAP device readout closest to 90 days after the start of CPAP therapy (minimum 60 days of monitoring). Compared between participants with and without chronic pain and with and without comorbid insomnia (Insomnia Severity Index \>= 15), analysed as a 2x2 design (pain x insomnia) including their interaction, adjusted for age, sex, AHI, BMI and length of the monitoring period. Readout rules and sensitivity analyses are described in the Detailed Description.
Time frame: From the start of CPAP therapy to the device readout closest to 3 months (90 days)
Prevalence of chronic pain in people with OSA undergoing CPAP treatment
Chronic pain defined as pain anywhere in the body that is present every day or most days for 3 months or longer and that regularly impairs quality of life or ability to do activities (leisure, work).
Time frame: Baseline
Average Pain during last 1 week
Participants are asked for the average pain they had during the last 1 week. They answer on a scale for 0-10 with 0 being no pain and 10 being the worst pain ever. This is a single question taken from the Brief Pain Inventory.
Time frame: 6-months after initiation of CPAP therapy
Fatigue (Mental and Physical)
Measured using the Brugmann Fatigue scale - 0-12 for each subscale (Mental fatigue and physical fatigue with 0 indicating no fatigue and 12 severe fatigue)
Time frame: 3 and 6 months after initiation of CPAP therapy
Sleepiness
Measured using the Epworth sleepiness scale - 0-24 with 0 indicating no sleepiness and 24 severe sleepiness.
Time frame: 3 and 6 months after initiation of CPAP therapy
Subjective sleep quality
Measured using the Pittsburgh Sleep quality index total score (0-21 with 0 indicating good sleep quality and 21 very bad sleep quality)
Time frame: 3 and 6 months after initiation of CPAP therapy
Depression
Measured using the depression subscale of the Hospital Anxiety and Depression Scale - 0-21 with 0 being no depressive symptomatology and 21 being severe depressive symptomatology
Time frame: 3 and 6 months after initiation of CPAP therapy
Anxiety
Measured using the anxiety subscale of the Hospital Anxiety and Depression Scale - 0-21 with 0 being no anxiety and 21 being severe anxiety
Time frame: 3 and 6 months after initiation of CPAP therapy
Self-reported health status
Measured using the Short Form 36 (SF-36) subscales with 0 indicating worse status and 100 indicating better health status in a domain
Time frame: 3 and 6 months after initiation of CPAP therapy
CPAP adherence rate at 3 months
Percentage of monitored nights with \>= 4 hours of CPAP use, and CPAP adherence (yes/no; adherence = \>= 4 hours on \>= 70% of monitored nights, non-adherence = not meeting this criterion), from the device readout closest to 90 days after the start of CPAP therapy (minimum 60 days of monitoring). Compared between participants with and without chronic pain and with and without comorbid insomnia, with the same analysis and covariates as the primary outcome on device-recorded CPAP use.
Time frame: From the start of CPAP therapy to the device readout closest to 3 months (90 days)
Device-recorded CPAP use and adherence at 6 months
Mean nightly CPAP use (hours/night, including nights without use), percentage of monitored nights with \>= 4 hours of use, and CPAP adherence (yes/no, as defined for the 3-month adherence outcome), from the device readout closest to 180 days after the start of CPAP therapy. Compared between participants with and without chronic pain and with and without comorbid insomnia, with the same analysis and covariates as the primary outcome on device-recorded CPAP use.
Time frame: From the start of CPAP therapy to the device readout closest to 6 months (180 days)
Plan to share: No
No publications or documents are linked to this record.
Started Mar 2025 (actual). Primary completion is estimated for Apr 2027, 25 months after the start.
Of 337 non-industry observational studies under Chronic Pain, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 56. This study's planned 25 months is close to that.
Counting every sponsor, half of 363 studies reached it within 24 months; a quarter within 12 and three quarters within 56.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 18, 2026: primary completion Dec 2025 → Apr 2027 and completion Apr 2026 → Aug 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.